Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

STARJEMZA

USTEKINUMAB-HMNY

Standard Dose
45MG/0.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview STARJEMZA is listed in Drugs@FDA under application 761419 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient USTEKINUMAB-HMNY Form and strength INJECTABLE;SUBCUTANEOUS - 45MG/0.5ML Sponsor BIO-THERA SOLUTIONS LTD Submission history Latest submission status date: 2025-05-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview STARJEMZA is listed in Drugs@FDA under application 761419 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient USTEKINUMAB-HMNY Form and strength INJECTABLE;SUBCUTANEOUS - 45MG/0.5ML Sponsor BIO-THERA SOLUTIONS LTD Submission history Latest submission status date: 2025-05-22 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.